MultiOmyx™: A novel chemistry and visualization tools to aid resolution of discrepant Hodgkin Lymphoma cases. A single slide multiplex assay for the evaluation of classical Hodgkin Lymphoma
Literature
Read More
NeoGenomics Reports Record Revenue of $16.9 Million, Adjusted EBITDA of $2.2 Million and Net Income of $900K for the Third Quarter 2013
Press Release
Read More
Highly multiplexed single-cell analysis of formalinfixed, paraffin-embedded cancer tissue
Literature
Read More
MultiOmyx™: A novel multiplex methodology for the evaluation of Hodgkin Lymphoma
Literature
Read More
The use of FISH in detecting ROS1 gene rearrangements in non-small cell lung cancer
Literature
Read More
NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter
Press Release
Read More